Events

CHAMPIONING CHOICE IN A MULTI-PRODUCT HIV PREVENTION MARKET

New products, including the dapivirine vaginal ring and injectable cabotegravir, have been approved in several countries, and more biomedical prevention products are in development. As the catalog of HIV prevention products expands, so too does the conversation about the importance of upholding choice to optimize the benefits for potential PrEP users.

Continue Reading

Events

PARENTS, PARTNERS, AND PEERS: THE ROLE OF INFLUENCERS IN ADOLESCENT GIRLS’ AND YOUNG WOMEN’S PrEP USE

We know that adolescent girls and young women live complex lives full of important relationships that shape the decisions they make. Yet too often efforts to generate demand for PrEP fail to reach beyond the individual user to her support system—those trusted people in her life who she leans on when making important choices. But demand generation for PrEP is evolving.

Continue Reading

Events

WHAT’S NEXT FOR CAB PrEP?

In this webinar, we explore ongoing and completed research on CAB PrEP, learn about the recently released FDA guidance, and hear from a panel of implementers and policymakers on what is needed to advance introduction of this new HIV prevention product.

Continue Reading